Free Newsletter
Sanofi to build vaccine plant in China
Vaccines made in China--for China. Sanofi Pasteur says it's spending about $104 million on a Chinese manufacturing plant in hopes of launching flu shots locally by 2012. The plant will be in Shenzhen, South China, where the company already operates a filling and packing facility. Construction on the plant will start next year. When it's up and running, it will have 100 employees and a capacity of 25 million doses, but Sanofi hopes to double that within 10 to 15 years.
- read the report from Dow Jones
Related Articles:
Sanofi signs stem cell pact in China. Report
Sanofi vaccine effective against new bird flu strains. Report
China pushes drug development as R&D soars. Report
More stories about drug development
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: